Adam Grippin
Adam Grippin is an oncologist at MD Anderson Cancer Center and a co-author of a groundbreaking study published in Nature, which reveals that mRNA COVID-19 vaccines may enhance the effectiveness of immunotherapy treatments for skin and lung cancer, offering new hope for patients.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 1 | 8.00 | 0.09% | +0% | 8,654,622 | 7,911 | $700,000 | 640$ |
| Totals | 1 | 8,654,622 | 7,911 | $700,000 | 640$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Adam Grippin, a former lab colleague of Sayour, analyzed patient records to find that those who received the mRNA Covid vaccine lived significantly longer.
8
Liechtenstein:
Adam Grippin is the lead author of the study published in Nature.
8
Romania:
Adam Grippin is an oncologist at MD Anderson Cancer Center and co-author of the study published in Nature.
9